Ignite Creation Date:
2024-05-06 @ 12:03 PM
Last Modification Date:
2024-10-26 @ 12:53 PM
Study NCT ID:
NCT03663335
Status:
COMPLETED
Last Update Posted:
2022-06-13
First Post:
2018-06-04
Brief Title:
Study of Efficacy Safety Tolerability Pharmacokinetic PK and Pharmacodynamic PD of an Anti-CD40 Monoclonal Antibody CFZ533 in Kidney Transplant Recipients
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Organization Data
Organization:
Novartis
Class:
INDUSTRY
Study ID:
CCFZ533A2201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Novartis Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None